Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Cancer Research
|
April 28, 2001
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas
H Ding, L Roncari, P Shannon, et al.
Cancer
|
June 8, 2001
Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome
M Zielenska, Z M Zhang, K Ng, et al.
Leukemia
|
July 2, 2003
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome
E Kolomietz, P Marrano, K Yee, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
August 21, 2010
Genomic alterations detected by comparative genomic hybridization in ovarian endometriomas
L C Veiga-Castelli, J C Rosa E Silva, J Meola, et al.
Molecular and Cellular Biology
|
February 18, 1999
Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts
H Vaziri, J A Squire, T K Pandita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2011
Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
J I Weberpals, D Tu, J A Squire, et al.
Cytogenetic and Genome Research
|
August 12, 2004
High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue
M Zielenska, P Marrano, P Thorner, et al.
British Journal of Cancer
|
April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
M Koti, A Siu, I Clément, et al.
Gynecologic Oncology
|
January 18, 2016
First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16
J I Weberpals, M S Amin, B E Chen, et al.
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Cancer Research
|
April 28, 2001
Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas
H Ding, L Roncari, P Shannon, et al.
Cancer
|
June 8, 2001
Acquisition of secondary structural chromosomal changes in pediatric ewing sarcoma is a probable prognostic factor for tumor response and clinical outcome
M Zielenska, Z M Zhang, K Ng, et al.
Leukemia
|
July 2, 2003
Quantitative PCR identifies a minimal deleted region of 120 kb extending from the Philadelphia chromosome ABL translocation breakpoint in chronic myeloid leukemia with poor outcome
E Kolomietz, P Marrano, K Yee, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
August 21, 2010
Genomic alterations detected by comparative genomic hybridization in ovarian endometriomas
L C Veiga-Castelli, J C Rosa E Silva, J Meola, et al.
Molecular and Cellular Biology
|
February 18, 1999
Analysis of genomic integrity and p53-dependent G1 checkpoint in telomerase-induced extended-life-span human fibroblasts
H Vaziri, J A Squire, T K Pandita, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 4, 2011
Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
J I Weberpals, D Tu, J A Squire, et al.
Cytogenetic and Genome Research
|
August 12, 2004
High-resolution cDNA microarray CGH mapping of genomic imbalances in osteosarcoma using formalin-fixed paraffin-embedded tissue
M Zielenska, P Marrano, P Thorner, et al.
British Journal of Cancer
|
April 1, 2015
A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
M Koti, A Siu, I Clément, et al.
Gynecologic Oncology
|
January 18, 2016
First application of the Automated QUantitative Analysis (AQUA) technique to quantify PTEN protein expression in ovarian cancer: A correlative study of NCIC CTG OV.16
J I Weberpals, M S Amin, B E Chen, et al.
Investigational New Drugs
|
May 19, 2015
A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195
B J Eigl, S North, E Winquist, et al.
Page
of 9